Internal Medicine, Medical Oncology · Aurora, CO
NPI
1720134315
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
12605 E 16th Ave
Aurora, CO, 80045
Phone (303) 493-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
181 services
Medicare patients, 2024
66
Average age 73
Drug cost, 2024
$994K
246 prescriptions
Company payments, 2025
$1,963
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Bowles was code 99215 (office e&m - established), 132 times for 50 patients. In total Daniel Bowles billed 181 services in 7 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 132 | 50 | $107.85 | $14K |
| 99215 Office E&M - Established | Office | 31 | 14 | $142.45 | $4,416 |
By year: 2022 $18K for 181 services; 2023 $20K for 202 services; 2024 $20K for 181 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Bowles prescribed most often to Medicare patients was Levothyroxine Sodium, with 25 prescriptions and refills. In total Daniel Bowles wrote 246 Medicare prescriptions that cost $994K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 25 | 72 | Under 11 | $190 |
| Gavreto Pralsetinib | 24 | 24 | Under 11 | $127K |
| Mekinist Trametinib Dimethyl Sulfoxide | 18 | 18 | Under 11 | $255K |
| Tafinlar Dabrafenib Mesylate | 18 | 18 | Under 11 | $234K |
| Bicalutamide Generic | 16 | 16 | Under 11 | $404 |
| Ondansetron Hcl Generic | 14 | 14 | Under 11 | $155 |
| Lenvima Lenvatinib Mesylate | 12 | 12 | Under 11 | $257K |
| Dexamethasone Generic | 11 | 13 | Under 11 | $207 |
| Prochlorperazine Maleate Generic | 11 | 11 | Under 11 | $203 |
Brand drugs: - claims; generic drugs: 141 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Bowles $1,963 ($1,963 in general payments such as food, travel and fees) from 8 companies. The largest payer was Eisai Inc. with $1,963.
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. 4523.T | 1 | $1,963 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.